Streetbeat News

Analyst Ratings

CC

RBC Capital has maintained its Sector Perform rating for Chemours (NYSE:CC) and raised its price target from $36.00 to $37.00. Shares of Chemours are currently trading down 3.21% at $31.94 per share.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 5:01 pm

LYB

In the last quarter, LyondellBasell Industries (NYSE:LYB) received 2 bullish, 4 somewhat bullish, 6 indifferent, and 2 somewhat bearish ratings from 14 analysts. The average price target is $102.36, implying an upside from the current price of $88.7039. The average price target has increased by 5.31% over the past month.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 5:00 pm

BRZE

UBS maintains its Neutral rating for Braze (NASDAQ:BRZE) and raises its price target from $35.00 to $38.00. Shares of Braze are trading up 18.47% over the last 24 hours, at $40.21 per share.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 5:00 pm

ZWS

Oppenheimer has maintained its Outperform rating for Zurn Elkay Water (NYSE:ZWS) and raised its price target from $27.00 to $29.00. ZWS shares are trading up 0.57% at $25.75 per share.

Portfolio Pulse from Benzinga Insights

June 09, 2023 | 5:00 pm

IRON

Raymond James analyst Danielle Brill upgrades Disc Medicine (NASDAQ:IRON) from Outperform to Strong Buy and raises the price target from $50 to $75.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 4:58 pm

CRSP

Needham analyst Gil Blum has reiterated a Buy rating on CRISPR Therapeutics (NASDAQ:CRSP) and raised the price target from $82 to $88.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 4:57 pm

DOCU

Citigroup analyst Tyler Radke reiterated a Buy rating on DocuSign (NASDAQ: DOCU) and raised the price target from $73 to $78.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 4:52 pm

TCOM

Trip.com shares are trading higher after receiving upgrades from analysts at Daiwa Capital and China Renaissance.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 4:51 pm

TFC

Citigroup analyst Keith Horowitz has reiterated a Buy rating on Truist Finl (NYSE:TFC) but lowered the price target from $48 to $46.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 4:50 pm

ORCL

Citigroup analyst Tyler Radke maintains a Neutral rating on Oracle (NYSE:ORCL) and raises the price target from $86 to $106.

Portfolio Pulse from Benzinga Newsdesk

June 09, 2023 | 4:48 pm